BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19637088)

  • 1. Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma.
    Gupta NK; Barker JN; Young JW; Noy A
    Leuk Lymphoma; 2009 Dec; 50(12):2075-7. PubMed ID: 19637088
    [No Abstract]   [Full Text] [Related]  

  • 2. Comeback for the camptothecins?
    Kirschbaum M
    Leuk Lymphoma; 2009 Dec; 50(12):1914-5. PubMed ID: 19860622
    [No Abstract]   [Full Text] [Related]  

  • 3. [Successful salvage therapy of continuous low-dose irinotecan for a patient with relapsed and refractory diffuse large B-cell lymphoma].
    Masaki Y; Sawaki T; Shimoyama K; Karasawa H; Kawanami T; Fukushima T; Kawabata H; Ogawa N; Wano Y; Sugai S; Hirose Y; Umehara H
    Rinsho Ketsueki; 2005 Sep; 46(9):1074-7. PubMed ID: 16440768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase.
    Kim YR; Kim SJ; Cheong JW; Yang DH; Lee H; Eom HS; Sung YO; Kim HJ; Kang HJ; Lee WS; Park Y; Yang WI; Min YH; Kim JS
    Ann Hematol; 2016 Sep; 95(9):1491-501. PubMed ID: 27324387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital.
    Innocenti F; Undevia SD; Ramírez J; Mani S; Schilsky RL; Vogelzang NJ; Prado M; Ratain MJ
    Clin Pharmacol Ther; 2004 Nov; 76(5):490-502. PubMed ID: 15536463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma: is there a place for autologous hematopoietic stem cell transplant in first remission in the era of chemo-immunotherapy?
    Nabhan C; Mehta J
    Leuk Lymphoma; 2012 Oct; 53(10):1859-66. PubMed ID: 22448919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.
    Rigacci L; Puccini B; Dodero A; Iacopino P; Castagna L; Bramanti S; Ciceri F; Fanin R; Rambaldi A; Falda M; Milone G; Guidi S; Martelli MF; Mazza P; Oneto R; Bosi A;
    Ann Hematol; 2012 Jun; 91(6):931-9. PubMed ID: 22245922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
    Hirose A; Yamane T; Nakajima Y; Manabe M; Kanashima H; Hagihara K; Sakamoto E; Nakamae M; Terada Y; Kosaka S; Aoyama Y; Sakamoto C; Kumura T; Koh KR; Hirai M; Ohta K; Nakao Y; Mugitani A; Teshima H; Hino M
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2059-64. PubMed ID: 16352929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide induced remission of refractory diffuse large B-Cell Lymphoma post-allogeneic SCT.
    Tueger S; Chen FE; Ahsan G; McDonald V; Andrews VE; Madrigal JA; Kazmi MA
    Haematologica; 2006 Jun; 91(6 Suppl):ECR16. PubMed ID: 16785122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose therapy and autologous stem cell transplantation in first relapse for diffuse large B cell lymphoma in the rituximab era: an analysis based on data from the European Blood and Marrow Transplantation Registry.
    Mounier N; Canals C; Gisselbrecht C; Cornelissen J; Foa R; Conde E; Maertens J; Attal M; Rambaldi A; Crawley C; Luan JJ; Brune M; Wittnebel S; Cook G; van Imhoff GW; Pfreundschuh M; Sureda A;
    Biol Blood Marrow Transplant; 2012 May; 18(5):788-93. PubMed ID: 22005647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose therapy and autologous stem cell transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
    Papajik T; Raida L; Faber E; Vondrakova J; Prochazka V; Kubova Z; Skoumalova I; Jarosova M; M LK; Paucek B; Myslivecek M; Neoral C; Oral I; Jarkovsky J; Dusek L; Indrak K
    Neoplasma; 2008; 55(3):215-21. PubMed ID: 18348654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
    Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
    Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory diffuse large B-cell lymphoma by chidamide combined with autologous stem cell transplantation: a case report.
    Wu P; Ma T; Chen Y; Wang F; Chen Y; Gao J; Zhou Z; Jia Y
    Anticancer Drugs; 2021 Sep; 32(8):886-889. PubMed ID: 34145178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Patients With Histologic Transformation.
    Reddy NM
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S100-S104. PubMed ID: 28760294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation.
    Yamamoto R; Takaori-Kondo A; Kanda J; Imada K; Ichinohe T; Ishikawa T; Ohmori K; Uchiyama T
    Bone Marrow Transplant; 2008 Mar; 41(6):591-3. PubMed ID: 18071292
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematopoietic cell transplantation for lymphomas.
    Ayala E; Tomblyn M
    Cancer Control; 2011 Oct; 18(4):246-57. PubMed ID: 21976243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of front-line autologous transplant in anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma.
    Holtan SG; Feldman AL; Knudson RA; Ketterling RP; Porrata LF
    Bone Marrow Transplant; 2011 Jun; 46(6):904-5. PubMed ID: 20818450
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
    Desai AA; Kindler HL; Taber D; Agamah E; Mani S; Wade-Oliver K; Ratain MJ; Vokes EE
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):421-6. PubMed ID: 15895230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic stem cell transplantation for diffuse large B cell lymphoma: defining the role of allografts.
    Uhm J; Kuruvilla J
    Transfus Apher Sci; 2013 Aug; 49(1):63-71. PubMed ID: 23790650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.